Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD | Zendy

Luciano Corda | Zendy; Giuseppe La Piana | Zendy; E. Bertella | Zendy; Luigi TarantoMontemurro | Zendy; Laura Pini | Zendy; Claudio Tantucci | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dose-response curve to salbutamol during acute and chronic treatment with formoterol in COPD

Author(s) -

Luciano Corda,

Giuseppe La Piana,

E. Bertella,

Luigi TarantoMontemurro,

Laura Pini,

Claudio Tantucci

Publication year - 2011

Publication title -

international journal of copd

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 67

eISSN - 1178-2005

pISSN - 1176-9106

DOI - 10.2147/copd.s22179

Subject(s) - medicine , formoterol , salbutamol , copd , bronchodilator agents , bronchodilator , adrenergic beta agonists , anesthesia , asthma , agonist , budesonide , receptor

Use of short-acting β(2)-agonists in chronic obstructive pulmonary disease (COPD) during treatment with long-acting β(2)-agonists is recommended as needed, but its effectiveness is unclear. The purpose of this study was to assess the additional bronchodilating effect of increasing doses of salbutamol during acute and chronic treatment with formoterol in patients with COPD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research